Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 9:32 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 985–1008 of 6,198 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Medication Group Clear all

Conditions: Focus of Study Pain Knowledge
Interventions: Pain education; Other
Lead sponsor: Belmont University; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Opioid Use, Opioid Use Disorder, Cocaine Use, Cocaine Use Disorder
Interventions: DynamiCare Health, Methadone Treatment-As-Usual; Behavioral · Drug
Lead sponsor: Friends Research Institute, Inc.; Other
Eligibility: 18 Years and older
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 5
States / cities: Baltimore, Maryland

Conditions: Mild Asthma
Interventions: Albuterol/Budesonide, Albuterol; Combination Product
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 120 Years
Enrollment: 101 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 16
States / cities: Phoenix, Arizona • Tucson, Arizona • Lancaster, California + 13 more

Conditions: Staff Attitude, Dementia
Interventions: Changing Talk Online (CHATO); Behavioral
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 219 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 2
States / cities: Iowa City, Iowa • Kansas City, Kansas

Conditions: Spinal Cord Injuries, Spinal Cord Injury Cervical
Interventions: Bidirectional Neural Bypass System; Device
Lead sponsor: Chad Bouton; Other
Eligibility: 22 Years to 65 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2028
U.S. locations: 1
States / cities: Manhasset, New York

Conditions: Ischemic and Non-ischemic Cardiomyopathy
Interventions: Medtronic ICD with Opti Vol-Monitor; Device
Lead sponsor: University of Rochester; Other
Eligibility: 18 Years to 85 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Pain, Postoperative
Interventions: Ibuprofen 600 mg, Local anesthetic Group 1, Placebo oral capsule, Local anesthetic Control; Drug
Lead sponsor: Satheesh Elangovan; Other
Eligibility: 18 Years to 64 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Burnout, Professional, Self Compassion, Flourishing, Imposter Syndrome, Moral Injury
Interventions: Better Together Physician Coaching Program, No intervention - placebo control; Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: Male only
Enrollment: 41 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Acne Vulgaris
Interventions: NVN1000 4% Gel, Vehicle Gel; Drug
Lead sponsor: Novan, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013
U.S. locations: 1
States / cities: Broomall, Pennsylvania

Conditions: Complication of Prematurity, Immunologic Deficiency Syndromes
Interventions: Adjuvant, Blood Collection; Other
Lead sponsor: University of Florida; Other
Eligibility: Up to 55 Years
Enrollment: 142 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2022
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Opioid-Related Disorders
Interventions: AV411, Placebo (PCB); Drug
Lead sponsor: New York State Psychiatric Institute; Other
Eligibility: 21 Years to 45 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2012
U.S. locations: 1
States / cities: New York, New York

Conditions: Hiv
Interventions: DOT mobile app; Other
Lead sponsor: Environment and Health Group, Inc.; Industry
Eligibility: 18 Years to 35 Years · Male only
Enrollment: 108 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Cambridge, Massachusetts

Conditions: Alcohol Use Disorders, Bipolar Disorder
Interventions: Zonisamide, Placebo; Drug
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: West Haven, Connecticut

Conditions: Acute Stroke
Interventions: SCM, SCM and VSSP; Other
Lead sponsor: Michigan State University; Other
Eligibility: 18 Years and older
Enrollment: 320 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 3
States / cities: Ann Arbor, Michigan • Lansing, Michigan • Ypsilanti, Michigan

Conditions: Arthritis, Juvenile
Interventions: Ren-Ex Machine, Dual-Emission X-ray Absorptiometry (DEXA) scan, Biodex dynamometer, Sub-maximal test, Quality of life questionnaires; Other
Lead sponsor: Johns Hopkins University; Other
Eligibility: 10 Years to 21 Years
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Substance Abuse, Child Abuse, Child Neglect
Interventions: Comprehensive Community Treatment, MST-BSF; Behavioral
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 6 Years and older
Enrollment: 191 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2016
U.S. locations: 1
States / cities: New Britain, Connecticut

Conditions: Overweight, Obesity, Healthy
Interventions: PF-08653944; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: HIV-1-infection
Interventions: GS-3242 Tablet, GS-3242 Injection, Lenacapavir Tablet, Lenacapavir Injection, B/F/TAF; Drug
Lead sponsor: Gilead Sciences; Industry
Eligibility: 18 Years and older
Enrollment: 700 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2033
U.S. locations: 15
States / cities: Torrance, California • New Haven, Connecticut • Ft. Pierce, Florida + 11 more

Conditions: Endometriosis Related Pain
Interventions: Relugolix, Estradiol/norethindrone acetate, Estradiol/norethindrone acetate placebo, Relugolix placebo; Drug
Lead sponsor: Myovant Sciences GmbH; Industry
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 623 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 41
States / cities: Andalusia, Alabama • Washington D.C., District of Columbia • Aventura, Florida + 36 more

Conditions: Rectal Cancer
Interventions: Capecitabine, Irinotecan, EUS, Neoadjuvant Chemotherapy, Preoperative Radiation, Surgery, Adjuvant Chemotherapy; Drug · Procedure
Lead sponsor: Gabi Chiorean, MD; Other
Eligibility: 18 Years and older
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 9
States / cities: Elkhart, Indiana • Fort Wayne, Indiana • Goshen, Indiana + 5 more

Conditions: HIV
Interventions: maraviroc; Drug
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 31 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Atypical Squamous Cell of Undetermined Significance, Cervical Carcinoma, Cervical Intraepithelial Neoplasia Grade 2/3, Health Status Unknown, Human Papillomavirus Infection, Low Grade Cervical Squamous Intraepithelial Neoplasia, Stage 0 Cervical Cancer
Interventions: Cervical Papanicolaou Test, Cytology Specimen Collection Procedure, Questionnaire Administration, Screening Method; Other · Procedure
Lead sponsor: University of Washington; Other
Eligibility: 21 Years and older · Female only
Enrollment: 1,335 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2017
U.S. locations: 2
States / cities: Minneapolis, Minnesota • Seattle, Washington

Conditions: Baseline Epidemiologic Assessment
Interventions: MorphaBond ER, Comparator Drug; Drug
Lead sponsor: Daiichi Sankyo; Industry
Eligibility: Not listed
Enrollment: 17,566 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Basking Ridge, New Jersey

Conditions: Diabetes Mellitus Type 2 - Insulin-Treated
Interventions: Smartphone application and web portal, Standard Insulin Therapy Education; Device · Behavioral
Lead sponsor: Linda Siminerio; Other
Eligibility: 18 Years to 75 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Search by objective public record fields.

Contemporary Pain Science Education and Physician Assistant Students

Treating Polysubstance Use Using a Novel Digital Technology

Study to Investigate Changes in Airway Inflammation, Symptoms, and Rescue Therapy Utilization With AIRSUPRA Compared to Albuterol as Needed in Adults With Mild Asthma

Changing Talk Online (CHATO) Study

Restoring Motor and Sensory Hand Function in Tetraplegia Using a Neural Bypass System

OptiVol for Precision Medical Management of Heart Failure

Pre-Emptive Analgesia in Dental Implant Surgery

Better Together Physician Coaching to Mitigate Burnout in Male-Identifying Trainees

A Phase 1 Study Evaluating Safety and Tolerability of NVN1000 Gel

Novel Mechanisms and Approaches to Treat Neonatal Sepsis

Phase IIa Study of AV411, a Glial Activation Inhibitor, for Opioid Withdrawal

Mhealth for PrEP Adherence by Young Adult MSM, Phase 2

Zonisamide for Heavy Drinkers With Bipolar Disorder

Michigan Stroke Transitions Trial

Exercise and Body Composition in Juvenile Idiopathic Arthritis

Family-Based Treatment for Parental Substance Abuse and Child Maltreatment

A Study to Learn How the Study Medicine Called PF-08653944 is Taken up Into the Blood in Adults With Overweight or Obesity

Study of an Injectable Regimen of GS-3242 With Lenacapavir Compared to Biktarvy in People New to HIV-1 Treatment

SPIRIT 2: Efficacy and Safety Study of Relugolix in Women With Endometriosis-Associated Pain

Capecitabine + Irinotecan Followed by Combined Modality Capecitabine and Radiation in Locally Advanced Rectal Cancer

Exploring HIV Entry Blockade as a Pre-exposure Prophylaxis Strategy in Women

Home-Based or Clinic-Based Human Papillomavirus (HPV) Screening

Baseline Epidemiologic Assessment of Abuse-Deterrence of MorphaBond Extended Release (BEAD-MB)

My Dose Coach Mobile App to Support Insulin Titration and Maintenance